A detailed history of Franklin Street Advisors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Franklin Street Advisors Inc holds 8,060 shares of ABT stock, worth $952,127. This represents 0.06% of its overall portfolio holdings.

Number of Shares
8,060
Previous 7,611 5.9%
Holding current value
$952,127
Previous $791,000 16.18%
% of portfolio
0.06%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$100.07 - $118.13 $44,931 - $53,040
449 Added 5.9%
8,060 $919,000
Q2 2024

Jul 18, 2024

SELL
$100.73 - $112.44 $76,655 - $85,566
-761 Reduced 9.09%
7,611 $791,000
Q1 2024

Apr 15, 2024

BUY
$109.52 - $120.96 $217,506 - $240,226
1,986 Added 31.1%
8,372 $952,000
Q2 2023

Jul 13, 2023

BUY
$100.78 - $112.29 $373,490 - $416,146
3,706 Added 138.28%
6,386 $696,000
Q4 2022

Feb 07, 2023

SELL
$95.06 - $111.52 $19,012 - $22,304
-200 Reduced 6.94%
2,680 $294,000
Q3 2022

Oct 11, 2022

SELL
$96.76 - $112.03 $4,354 - $5,041
-45 Reduced 1.54%
2,880 $279,000
Q2 2022

Jul 13, 2022

SELL
$102.07 - $123.37 $108,092 - $130,648
-1,059 Reduced 26.58%
2,925 $318,000
Q1 2022

Apr 18, 2022

BUY
$114.02 - $139.04 $67,727 - $82,589
594 Added 17.52%
3,984 $472,000
Q3 2021

Oct 22, 2021

SELL
$116.66 - $129.06 $3,733 - $4,129
-32 Reduced 0.94%
3,390 $400,000
Q2 2021

Aug 05, 2021

BUY
$105.79 - $124.53 $423 - $498
4 Added 0.12%
3,422 $397,000
Q1 2021

May 04, 2021

SELL
$108.84 - $128.23 $10,122 - $11,925
-93 Reduced 2.65%
3,418 $410,000
Q3 2020

Oct 21, 2020

BUY
$91.64 - $111.29 $61,398 - $74,564
670 Added 23.58%
3,511 $382,000
Q2 2020

Aug 06, 2020

SELL
$76.57 - $98.0 $55,589 - $71,148
-726 Reduced 20.35%
2,841 $260,000
Q1 2020

Apr 16, 2020

SELL
$62.82 - $91.86 $816 - $1,194
-13 Reduced 0.36%
3,567 $281,000
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $78,431 - $87,312
-999 Reduced 21.82%
3,580 $311,000
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $5,074 - $5,501
62 Added 1.37%
4,579 $383,000
Q2 2019

Aug 07, 2019

SELL
$72.88 - $85.0 $8,016 - $9,350
-110 Reduced 2.38%
4,517 $380,000
Q1 2019

May 14, 2019

BUY
$66.22 - $80.06 $331 - $400
5 Added 0.11%
4,627 $370,000
Q3 2018

Oct 05, 2018

BUY
$60.81 - $73.36 $49,560 - $59,788
815 Added 21.41%
4,622 $339,000
Q2 2018

Jul 16, 2018

BUY
$57.57 - $63.54 $219,168 - $241,896
3,807 New
3,807 $232,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Franklin Street Advisors Inc Portfolio

Follow Franklin Street Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Franklin Street Advisors Inc with notifications on news.